Clinical Trial Update: Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®

View source ↗

Summary

This ClinicalTrials.gov post-marketing surveillance study assesses long-term safety data for Ozempic (semaglutide) in adults with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED